Company Description

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals.

Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses.

The company's pipeline products also include therapeutic devices for veterinary and human clinical applications.

PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

PetVivo Holdings, Inc.

Country	MN
Industry	Medical Devices
Sector	Healthcare
Employees	25
CEO	John Lai

Contact Details

Address: 5251 Edina Industrial Blvd Edina, Minnesota 55439 United States
Phone	(952) 217-4952
Website	petvivo.com

Stock Details

Ticker Symbol	PETV
Exchange	OTCMKTS
Fiscal Year	April - March
Reporting Currency	USD
CIK Code	0001512922
CUSIP Number	716817408
ISIN Number	US7168174081
Employer ID	99-0363559
SIC Code	3841

Key Executives

Name	Position
John Lai	Chief Executive Officer, President and Director
Randall A. Meyer	Chief Operating Officer
Garry N. Lowenthal	Chief Financial Officer
Randy Wenthold	Chief Science Officer
John F. Dolan	General Counsel, Chief Business Development Officer and Secretary
Gary DeMel	Executive Vice President of Business Development
Russell Siakel	Director of Marketing

Latest SEC Filings

Date	Type	Title
Apr 22, 2024	8-K	Current Report
Apr 19, 2024	8-K	Current Report
Apr 16, 2024	8-K	Current Report
Apr 9, 2024	8-K	Current Report
Mar 18, 2024	SC 13G/A	[Amend] Statement of acquisition of beneficial ownership by individuals
Mar 14, 2024	8-K	Current Report
Mar 11, 2024	8-K	Current Report
Mar 7, 2024	424B5	Filing
Mar 6, 2024	8-K	Current Report
Feb 12, 2024	10-Q	Quarterly Report

View All SEC Filings